Article
Tumor suppressor gene mutations correlate with prognosis and immunotherapy benefit in hepatocellular carcinoma.
International immunopharmacology - 1 Dec 2021
Liu Zaoqu, Liu Long, Guo ChunGuang, Yu Sun, Meng Lingfang, Zhou Xueliang, Han Xinwei
Abstract excerpt
INTRODUCTION: The tumor microenvironment (TME) has profound impacts on prognosis and immunotherapy. The TME can be altered by the genomic mutations on specific tumor-suppressor genes (TSG), thus, comprehending the association between TME and TSG in hepatocellular carcinoma (HCC) is imperative. METHODS: With a total of 1699 HCC patients from 6 international multicenter cohorts, we delineated the mutational...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
